159 related articles for article (PubMed ID: 9256484)
1. Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5.
Cordelier P; Estève JP; Bousquet C; Delesque N; O'Carroll AM; Schally AV; Vaysse N; Susini C; Buscail L
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9343-8. PubMed ID: 9256484
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.
Buscail L; Estève JP; Saint-Laurent N; Bertrand V; Reisine T; O'Carroll AM; Bell GI; Schally AV; Vaysse N; Susini C
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1580-4. PubMed ID: 7878022
[TBL] [Abstract][Full Text] [Related]
3. Regulation of neuronal nitric-oxide synthase activity by somatostatin analogs following SST5 somatostatin receptor activation.
Cordelier P; Estève JP; Najib S; Moroder L; Vaysse N; Pradayrol L; Susini C; Buscail L
J Biol Chem; 2006 Jul; 281(28):19156-71. PubMed ID: 16690617
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of somatostatin and angiopeptin on cell proliferation.
Alderton F; Lauder H; Feniuk W; Fan TP; Humphrey PP
Br J Pharmacol; 1998 May; 124(2):323-30. PubMed ID: 9641549
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.
Florio T; Thellung S; Arena S; Corsaro A; Bajetto A; Schettini G; Stork PJ
J Physiol Paris; 2000; 94(3-4):239-50. PubMed ID: 11088001
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathways.
Arena S; Pattarozzi A; Corsaro A; Schettini G; Florio T
Mol Endocrinol; 2005 Jan; 19(1):255-67. PubMed ID: 15388796
[TBL] [Abstract][Full Text] [Related]
7. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
[TBL] [Abstract][Full Text] [Related]
8. Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop.
Peverelli E; Lania AG; Mantovani G; Beck-Peccoz P; Spada A
Endocrinology; 2009 Jul; 150(7):3169-76. PubMed ID: 19342453
[TBL] [Abstract][Full Text] [Related]
9. The pivotal role of phosphoinositide-3 kinase in the human somatostatin sst(4) receptor-mediated stimulation of p44/p42 mitogen-activated protein kinase and extracellular acidification.
Smalley KS; Feniuk W; Sellers LA; Humphrey PP
Biochem Biophys Res Commun; 1999 Sep; 263(1):239-43. PubMed ID: 10486283
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells.
Lauder H; Sellers LA; Fan TP; Feniuk W; Humphrey PP
Br J Pharmacol; 1997 Oct; 122(4):663-70. PubMed ID: 9375962
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells.
Gendron L; Côté F; Payet MD; Gallo-Payet N
Neuroendocrinology; 2002 Jan; 75(1):70-81. PubMed ID: 11810036
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
[TBL] [Abstract][Full Text] [Related]
13. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction of somatostatin receptors negatively controlling cell proliferation.
Ferjoux G; Bousquet C; Cordelier P; Benali N; Lopez F; Rochaix P; Buscail L; Susini C
J Physiol Paris; 2000; 94(3-4):205-10. PubMed ID: 11087998
[TBL] [Abstract][Full Text] [Related]
15. Activation of human somatostatin receptor type 2 causes inhibition of cell growth in transfected HEK293 but not in transfected CHO cells.
Ren J; Bell G; Coy DH; Brunicardi FC
J Surg Res; 1997 Jul; 71(1):13-8. PubMed ID: 9271272
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory role of the somatostatin receptor SST2 on the intracrine-regulated cell proliferation induced by the 210-amino acid fibroblast growth factor-2 isoform: implication of JAK2.
Hortala M; Ferjoux G; Estival A; Bertrand C; Schulz S; Pradayrol L; Susini C; Clemente F
J Biol Chem; 2003 Jun; 278(23):20574-81. PubMed ID: 12665520
[TBL] [Abstract][Full Text] [Related]
17. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation.
Ben-Shlomo A; Pichurin O; Barshop NJ; Wawrowsky KA; Taylor J; Culler MD; Chesnokova V; Liu NA; Melmed S
Mol Endocrinol; 2007 Oct; 21(10):2565-78. PubMed ID: 17609435
[TBL] [Abstract][Full Text] [Related]
18. Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells.
Murthy KS; Jin JG; Grider JR; Makhlouf GM
Am J Physiol; 1997 Jun; 272(6 Pt 1):G1391-9. PubMed ID: 9227474
[TBL] [Abstract][Full Text] [Related]
19. Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling.
Lopez F; Ferjoux G; Cordelier P; Saint-Laurent N; Estève JP; Vaysse N; Buscail L; Susini C
FASEB J; 2001 Oct; 15(12):2300-2. PubMed ID: 11511520
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells.
Dabrowski A; Detjen KM; Logsdon CD; Williams JA
Digestion; 1997; 58(4):361-7. PubMed ID: 9324163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
